Ann: Initial Assays from Hole 1 - 64North Project Alaska, page-131

Well to me its like "deja vu" all over again. RAP's shareprice also fell 60% within a day not long ago. After too much hype about an "imminent" FDA approval (3rd attempt) and a contract with Sanofi, RAP announced on the same day that it had failed both, leaving SH very very frustrated. An urgent conference call was arranged. Those whom attended later that day went on HC saying they would buy more and would become very rich because of RAP. I guess everyone was laughing at them. Few weeks later, RAP sealed a few deals and their SP rocketted from 7.4c to 22c. Well, we will see how this one turns out to be.